Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia.

Zhihua Ran, Kaichun Wu, Katsuyoshi Matsuoka, Yoon Tae Jeen, Shu Chen Wei, Vineet Ahuja, Minhu Chen, Pin-Jin Hu, Akira Andoh, Hyo Jong Kim, Suk-Kyun Yang, Mamoru Watanabe, Siew Chien Ng, Toshifumi Hibi, Ida Normiha Hilmi, Yasuo Suzuki, Dong Soo Han, Wai Keung Leung, Jose Sollano, Choon Jin Ooi, Jiaming Qian

Journal: Journal of gastroenterology and hepatology 2021;36(3):637-645

PMID: 32672839

Abstract

Inflammatory bowel disease (IBD) has increased in incidence and prevalence in Asian countries since the end of the 20th century. Moreover, differences in the cause, phenotypes, and natural history of IBD between the East and West have been recognized. Therefore, the Asian Organization for Crohn's and Colitis and the Asia Pacific Association of Gastroenterology have established recommendations on medical management of IBD in Asia. Initially, the committee members drafted 40 recommendations, which were then assessed according to Grading of Recommendations Assessment, Development and Evaluation. Eight statements were rejected as this indicated that consensus had not been reached. The recommendations encompass pretreatment evaluation; medical management of active IBD; medical management of IBD in remission; management of IBD during the periconception period and pregnancy; surveillance strategies for colitis-associated cancer; monitoring side effects of thiopurines and methotrexate; and infections in IBD.

© 2020 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Address: Department of Gastroenterology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.; Department of Gastroenterology, Fourth Military Medical University, Xi'an, China.; Department of Gastroenterology, Toho University Sakura Medical Center, Chiba, Japan.; Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.; Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India.; Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.; Department of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.; Department of Gastroenterology, Shiga University, Otsu, Japan.; Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, Korea.; Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.; Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, Tokyo, Japan.; Department of Medicine and Therapeutics, Institute of Digestive Disease, LKS Institute of Health Science, State Key Laboratory of Digestive Disease, The Chinese University of Hong Kong, Hong Kong.; Center for Advanced IBD Research and Treatment, Kitasato University, Tokyo, Japan.; Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia.; Department of Internal Medicine, Toho University, Sakura, Japan.; Department of Internal Medicine, Hanyang University Guri Hospital, Guri, Korea.; Division of Gastroenterology and Hepatology, Department of Medicine, University of Hong Kong, Hong Kong.; Department of Medicine, University of Santo Tomas, Manila, Philippines.; Gleneagles Medical Centre and Duke-NUS Medical School, Singapore.; Department of Gastroenterology, Peking Union Medical College, Beijing, China.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.